Speakers

Luigi Angelillo, Director, Market Access EMEA, Argenx

Luigi Angelillo | Director, Market Access EMEA | Argenx » speaking at World EPA Congress

Ad Antonisse, Director Market Access & External Affairs, AstraZeneca BV

Ad Antonisse | Director Market Access & External Affairs | AstraZeneca BV » speaking at World EPA Congress

Fausto Artico, Global R&D Tech Head of Innovation & Data Science, GSK

Fausto Artico | Global R&D Tech Head of Innovation & Data Science | GSK » speaking at World EPA Congress

Marnix Artz, Head of Patient Access, Pricing & Public Affairs, Netherlands, Merck Group

Marnix Artz | Head of Patient Access, Pricing & Public Affairs, Netherlands | Merck Group » speaking at World EPA Congress

Cecilie Astrup, Health economist, Amgros I/S

Cecilie Astrup | Health economist | Amgros I/S » speaking at World EPA Congress

Yumi Asukai, Senior Director, Gilead Sciences Ltd

Yumi Asukai | Senior Director | Gilead Sciences Ltd » speaking at World EPA Congress

Marta Baldrighi, Policy and Science Officer, Medicines for Europe

Marta Baldrighi | Policy and Science Officer | Medicines for Europe » speaking at World EPA Congress

Giovanna Barcelos, HEOR RWE Senior Manager, Europe & GCC, Global Blood Therapeutics

Giovanna Barcelos | HEOR RWE Senior Manager, Europe & GCC | Global Blood Therapeutics » speaking at World EPA Congress

Dorothee Bartels, Global Head RWE, UCB

Dorothee Bartels | Global Head RWE | UCB » speaking at World EPA Congress

Alexander Bastian, VP Value & Market Access, A.M. Pharma

Alexander Bastian | VP Value & Market Access | A.M. Pharma » speaking at World EPA Congress

Tomer Ben Zaken, Regional Business Operation Lead, Takeda

Tomer Ben Zaken | Regional Business Operation Lead | Takeda » speaking at World EPA Congress

Nadia Benhadi, Eu Market Access And Pricing Director, GlaxoSmithKline

Nadia Benhadi | Eu Market Access And Pricing Director | GlaxoSmithKline » speaking at World EPA Congress

Jesper Bjerggren, European Market Access Lead Respiratory/Digital Health, Teva Pharmaceuticals

Jesper Bjerggren | European Market Access Lead Respiratory/Digital Health | Teva Pharmaceuticals » speaking at World EPA Congress

Marie-sharmila Blandino, Marketing Manager, Amgen

Marie-sharmila Blandino | Marketing Manager | Amgen » speaking at World EPA Congress

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Axel Boehnke | Director Market Access EU North | PTC Therapeutics » speaking at World EPA Congress

Amanda Bok, Chief Executive Officer, European Haemophilia Consortium

Amanda Bok | Chief Executive Officer | European Haemophilia Consortium » speaking at World EPA Congress

thomas bols, head of government affairs and patient advocacy, EMEA & APAC, PTC Therapeutics

thomas bols | head of government affairs and patient advocacy, EMEA & APAC | PTC Therapeutics » speaking at World EPA Congress

Vidya Breeveld, Founder, Transmineo

Vidya Breeveld | Founder | Transmineo » speaking at World EPA Congress

Rob Burley, Director Of Campaigns, Care And Support, The Muscular Dystrophy U.K.

Rob Burley | Director Of Campaigns, Care And Support | The Muscular Dystrophy U.K. » speaking at World EPA Congress

Astrid Buys, Global Head of Tenders & Pricing, Bavarian Nordic A/S

Astrid Buys | Global Head of Tenders & Pricing | Bavarian Nordic A/S » speaking at World EPA Congress

Sandro Cesaro, Head, Market Access and Innovative Value Strategies, Oncology Europe, AstraZeneca

Sandro Cesaro | Head, Market Access and Innovative Value Strategies, Oncology Europe | AstraZeneca » speaking at World EPA Congress

Mata Charokopou, Head of Payer value Strategy, UCB

Mata Charokopou | Head of Payer value Strategy | UCB » speaking at World EPA Congress

Helene Chevrou-Severac, HEOR RWE Centre of Excellence Head, International & Japan, Alexion

Helene Chevrou-Severac | HEOR RWE Centre of Excellence Head, International & Japan | Alexion » speaking at World EPA Congress

José Luis Sánchez Chorro, Market Access Director Spain and Portugal, Jazz Pharmaceuticals

José Luis Sánchez Chorro | Market Access Director Spain and Portugal | Jazz Pharmaceuticals » speaking at World EPA Congress

Sally Chung, VP, Head of Market Access & Pricing Europe, GSK

Sally Chung | VP, Head of Market Access & Pricing Europe | GSK » speaking at World EPA Congress

Friso Coerts, Market Access & HTA Manager, Pfizer

Friso Coerts | Market Access & HTA Manager | Pfizer » speaking at World EPA Congress

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics

Jean-Philippe Combal | Co-Founder And Chief Executive Officer | Vivet Therapeutics » speaking at World EPA Congress

Stephen Connell, Director Payer Insights & Access, Pfizer Ltd

Stephen Connell | Director Payer Insights & Access | Pfizer Ltd » speaking at World EPA Congress

Rossella Di Bidino, HTA expert, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rossella Di Bidino | HTA expert | Fondazione Policlinico Universitario Agostino Gemelli IRCCS » speaking at World EPA Congress

Anna Dickinson, Policy Manager, Public Policy Projects

Anna Dickinson | Policy Manager | Public Policy Projects » speaking at World EPA Congress

Toon Digneffe, Head Public Affairs & Public Policy, Europe & Cana, Takeda

Toon Digneffe | Head Public Affairs & Public Policy, Europe & Cana | Takeda » speaking at World EPA Congress

Marcus Droege, Vice President, Global Value & Market Access, Passage Bio

Marcus Droege | Vice President, Global Value & Market  Access | Passage Bio » speaking at World EPA Congress

Gilles Ducorroy, Global Head of RWE Services, Novartis

Gilles Ducorroy | Global Head of RWE Services | Novartis » speaking at World EPA Congress

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at World EPA Congress

Frederic Ernst, Head of Market Access for Europe, Santen

Frederic Ernst | Head of Market Access for Europe | Santen » speaking at World EPA Congress

Gina Ewy, Head Global Market Access, Hansa Biopharma

Gina Ewy | Head Global Market Access | Hansa Biopharma » speaking at World EPA Congress

Marina Faiella, Director of Hematology Market Access Europe, Beigene

Marina Faiella | Director of Hematology Market Access Europe | Beigene » speaking at World EPA Congress

Stefaan Fiers, Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda

Stefaan Fiers | Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium | Takeda » speaking at World EPA Congress

Graham Foxon, Managing Director, remap consulting

Graham Foxon | Managing Director | remap consulting » speaking at World EPA Congress

Stefan Franzen, Director, Medical & Payer Evidence Statistics, AstraZeneca

Stefan Franzen | Director, Medical & Payer Evidence Statistics | AstraZeneca » speaking at World EPA Congress

Pat Garcia-Gonzalez, Chief Executive Officer, THE MAX FOUNDATION

Pat Garcia-Gonzalez | Chief Executive Officer | THE MAX FOUNDATION » speaking at World EPA Congress

Philippe Ghyssels, VP Corporate and Global Public Affairs, ipsen

Philippe Ghyssels | VP Corporate and Global Public Affairs | ipsen » speaking at World EPA Congress

Christoph Glaetzer, Chief Global Value and Access Officer, The Janssen Pharmaceutical Companies of Johnson & Johnson

Christoph Glaetzer | Chief Global Value and Access Officer | The Janssen Pharmaceutical Companies of Johnson & Johnson » speaking at World EPA Congress

Denise Globe, Head Global Health Economics and Outcomes Research Center of Excellence, Gilead Sciences

Denise Globe | Head Global Health Economics and Outcomes Research Center of Excellence | Gilead Sciences » speaking at World EPA Congress

Josie Godfrey, Co-Founder and Chief Executive Officer, Realise Advocacy

Josie Godfrey | Co-Founder and Chief Executive Officer | Realise Advocacy » speaking at World EPA Congress

Wim Goettsch, Associate Professor of HTA, Utrecht Centre for Pharmaceutical Policy and Regulation

Wim Goettsch | Associate Professor of HTA | Utrecht Centre for Pharmaceutical Policy and Regulation » speaking at World EPA Congress

Alicia Granados, Head, Global Rare Diseases Scientific Advocacy, SANOFI

Alicia Granados | Head, Global Rare Diseases Scientific Advocacy | SANOFI » speaking at World EPA Congress

Laura Guarga, Consultant of Pharmacoeconomic Department, CatSalut

Laura Guarga | Consultant of Pharmacoeconomic Department | CatSalut » speaking at World EPA Congress

Sondes Hamida, Head of Medicines Assessment Department, Tunisian National Health Insurance Fund

Sondes Hamida | Head of Medicines Assessment Department | Tunisian National Health Insurance Fund » speaking at World EPA Congress

Gunter Harms, Senior Market Access Director, Novartis Gene Therapies

Gunter Harms | Senior Market Access Director | Novartis Gene Therapies » speaking at World EPA Congress

Tanja Heidbrede, Head RWE Central EU, UCB

Tanja Heidbrede | Head RWE Central EU | UCB » speaking at World EPA Congress

Giorgio Iotti, Head Of Program Leadership And Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Giorgio Iotti | Head Of Program Leadership And Control, Rare Disease Unit | Chiesi Farmaceutici SpA » speaking at World EPA Congress

Amy Israel, Vice President and Global Head, Oncology Policy & Healthcare Systems, Novartis

Amy Israel | Vice President and Global Head, Oncology Policy & Healthcare Systems | Novartis » speaking at World EPA Congress

Saira Jan, Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey

Saira Jan | Vice-President & Chief Pharmacy Officer | Blue Cross Blue Shield of New Jersey » speaking at World EPA Congress

Pall Jonsson, Programme director for Data, Nice

Pall Jonsson | Programme director for Data | Nice » speaking at World EPA Congress

Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, Roche

Gomathi Kaliappan | Health Systems Strategy Leader - Global Access | Roche » speaking at World EPA Congress

Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator applications

Lisette Kaskens | Senior Global Market Access Manager | Advanced Accelerator applications » speaking at World EPA Congress

Nadia Kaskure, Value Strategy Lead, novo nordisk

Nadia Kaskure | Value Strategy Lead | novo nordisk » speaking at World EPA Congress

Linda klein Holkenborg, Medical Advisor, CZ

Linda klein Holkenborg | Medical Advisor | CZ » speaking at World EPA Congress

Diane Kleinermans, President of the Commission of Drugs Reimbursement, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV)

Diane Kleinermans | President of the Commission of Drugs Reimbursement | Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) » speaking at World EPA Congress

Jolanda Koenders, Head of Patient Value and Access, Takeda Nederland

Jolanda Koenders | Head of Patient Value and Access | Takeda Nederland » speaking at World EPA Congress

Augusta Elizabeth Koroma, Chief Executive Officer, Sickle cell Intervention U.K

Augusta Elizabeth Koroma | Chief Executive Officer | Sickle cell Intervention U.K » speaking at World EPA Congress

Aleksandra Krygiel-Nael, Head of Government Affairs and Policy, Medical Devices, Johnson & Johnson

Aleksandra Krygiel-Nael | Head of Government Affairs and Policy, Medical Devices | Johnson & Johnson » speaking at World EPA Congress

Maria Kubin, Vice President of Global Market Access, Bayer Healthcare Ag

Maria Kubin | Vice President of Global Market Access | Bayer Healthcare Ag » speaking at World EPA Congress

Hannah Kurth, Global Value and Access Lead, Horizon Therapeutics

Hannah Kurth | Global Value and Access Lead | Horizon Therapeutics » speaking at World EPA Congress

Timothy Lenehan, CVP Global Evidence, Pricing and Access, Novo Nordisk

Timothy Lenehan | CVP Global Evidence, Pricing and Access | Novo Nordisk » speaking at World EPA Congress

Giovanny Leon, Pricing & Access Regional Director - LatAm & Canada, Novartis AG

Giovanny Leon | Pricing & Access Regional Director - LatAm & Canada | Novartis AG » speaking at World EPA Congress

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research | Pfizer » speaking at World EPA Congress

Gavin Lewis, Vice President Global Head of Market Access, Amgen

Gavin Lewis | Vice President Global Head of Market Access | Amgen » speaking at World EPA Congress

Herve Lilliu, Chief Executive Officer, Inbeeo

Herve Lilliu | Chief Executive Officer | Inbeeo » speaking at World EPA Congress

Elena Lungu, Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada

Elena Lungu | Manager of Policy Development, Patented Medicine Prices Review Board | Government of Canada » speaking at World EPA Congress

James Maddocks, International Policy Advisor, NHS Confederation

James Maddocks | International Policy Advisor | NHS Confederation » speaking at World EPA Congress

Joerg Mahlich, Market Access and Government Affairs Lead, Miltenyi Biomedicine GmbH

Joerg Mahlich | Market Access and Government Affairs Lead | Miltenyi Biomedicine GmbH » speaking at World EPA Congress

Bart Malfait, Director Government Affairs & Market Access (BeLux), Astra Zeneca

Bart Malfait | Director Government Affairs & Market Access (BeLux) | Astra Zeneca » speaking at World EPA Congress

Marco Marchetti, Director of Health Technology Assessment Unit, National Agency for Regional Care Services, Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas

Marco Marchetti | Director of Health Technology Assessment Unit, National  Agency for Regional Care Services | Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas » speaking at World EPA Congress

Marisca Marian, Market Access Strategy Leader, Bayer

Marisca Marian | Market Access Strategy Leader | Bayer » speaking at World EPA Congress

Linda Mcnamara, Market Access Director, Kyowa Kirin GmbH

Linda Mcnamara | Market Access Director | Kyowa Kirin GmbH » speaking at World EPA Congress

Rasha Mokaddem, Market Access Director, Johnson & Johnson

Rasha Mokaddem | Market Access Director | Johnson & Johnson » speaking at World EPA Congress

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

Paolo Morgese | EU Director Market Access & Member Relations | Alliance for Regenerative Medicine » speaking at World EPA Congress

Tal Morginstin, Director, HTA division, Ministry of Health

Tal Morginstin | Director, HTA division | Ministry of Health » speaking at World EPA Congress

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at World EPA Congress

Andrew Olaye, Head of EMEA Market Access, Orchard Therapeutics Ltd

Andrew Olaye | Head of EMEA Market Access | Orchard Therapeutics Ltd » speaking at World EPA Congress

Melvin Olson, Global Head Integrated Evidence Strategy and Innovation, Novartis

Melvin Olson | Global Head Integrated Evidence Strategy and Innovation | Novartis » speaking at World EPA Congress

Mario Ouwens, Group Director Medical & Payer Evidence Statistics, AstraZeneca

Mario Ouwens | Group Director Medical & Payer Evidence Statistics | AstraZeneca » speaking at World EPA Congress

Sandra Paci, Global Market Access And Pricing Director, Argenx

Sandra Paci | Global Market Access And Pricing Director | Argenx » speaking at World EPA Congress

Francis Pang, Senior Vice President, Global Market Access, Orchard Therapeutics

Francis Pang | Senior Vice President, Global Market Access | Orchard Therapeutics » speaking at World EPA Congress

Elena Panitti, Global Head Real World Evidence Excellence, Novartis

Elena Panitti | Global Head Real World Evidence Excellence | Novartis » speaking at World EPA Congress

Michela Pantaleoni, Head of Market Access Rare Diseases Europe & Emerg, Chiesi Global Rare Disease

Michela Pantaleoni | Head of Market Access Rare Diseases Europe & Emerg | Chiesi Global Rare Disease » speaking at World EPA Congress

Julien Patris, Director Market Access & Policy – Europe / Canada / MEA (CEMEA), Alnylam

Julien Patris | Director Market Access & Policy – Europe / Canada / MEA (CEMEA) | Alnylam » speaking at World EPA Congress

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim

Marco Penske | Head Of Market Access And Health Care Affairs | Boehringer-Ingelheim » speaking at World EPA Congress

Lara Pippo, Head Of Market Access, Italy, CSL Behring

Lara Pippo | Head Of Market Access, Italy | CSL Behring » speaking at World EPA Congress

Anke Pisters-van Roy, MD, CZ

Anke Pisters-van Roy | MD | CZ » speaking at World EPA Congress

Ana Plata, Head of Global Pricing Implementation BBU, AstraZeneca

Ana Plata | Head of Global Pricing Implementation BBU | AstraZeneca » speaking at World EPA Congress

Ludovica Polverino, Market Access Director, Daiichi Sankyo Development Ltd

Ludovica Polverino | Market Access Director | Daiichi Sankyo Development Ltd » speaking at World EPA Congress

Luis Prieto Rodriguez, Global Real-World Evidence Director, Novartis

Luis Prieto Rodriguez | Global Real-World Evidence Director | Novartis » speaking at World EPA Congress

Sonia Pulido, HTA Co-ordinator, Spanish Medicines Agency

Sonia Pulido | HTA Co-ordinator | Spanish Medicines Agency » speaking at World EPA Congress

Sreeram Ramagopalan, Global Head Real-World Evidence (Market Access), Roche

Sreeram Ramagopalan | Global Head Real-World Evidence (Market Access) | Roche » speaking at World EPA Congress

Nuno Prego Ramos, Chief Executive Officer, cellmabs

Nuno Prego Ramos | Chief Executive Officer | cellmabs » speaking at World EPA Congress

Marco Rauland, Vice President Global Market Access & Pricing - Strategic Planning, Merck Group

Marco Rauland | Vice President Global Market Access & Pricing - Strategic Planning | Merck Group » speaking at World EPA Congress

Laurene Redding, Head, Value, Access & Policy, Canada, Beigene

Laurene Redding | Head, Value, Access & Policy, Canada | Beigene » speaking at World EPA Congress

Peny Retsa, Market Access and External Relations Director, Abbvie

Peny Retsa | Market Access and External Relations Director | Abbvie » speaking at World EPA Congress

Sybille Riou, Global Market Access Manager, Miltenyi Biotec

Sybille Riou | Global Market Access Manager | Miltenyi Biotec » speaking at World EPA Congress

Igor Rudychev, Vice President, Enterprise Analytics, Horizon

Igor Rudychev | Vice President, Enterprise Analytics | Horizon » speaking at World EPA Congress

Sandrine Ruiz, Director Global Market Access and Pricing, Independent

Sandrine Ruiz | Director Global Market Access and Pricing | Independent » speaking at World EPA Congress

Marcelo Sal, Head of Market Access and Pricing, South Cone of South America, PTC Therapeutics

Marcelo Sal | Head of Market Access and Pricing, South Cone of South America | PTC Therapeutics » speaking at World EPA Congress

Steve Sandor, Vice President of Market Access and Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President of Market Access and Trade | Paratek Pharmaceuticals , Inc. » speaking at World EPA Congress

Sophie Schmitz, Managing Partner, Partners4Access

Sophie Schmitz | Managing Partner | Partners4Access » speaking at World EPA Congress

Michael Schroter, Co-Head Sustainable Healthcare Equity, HSBC

Michael Schroter | Co-Head Sustainable Healthcare Equity | HSBC » speaking at World EPA Congress

Ayman Semaan, Head of Market Access, Biologix

Ayman Semaan | Head of Market Access | Biologix » speaking at World EPA Congress

Maja Sercic, Policy & Science Manager, Medicines for Europe

Maja Sercic | Policy & Science Manager | Medicines for Europe » speaking at World EPA Congress

Hans Severens, Scientific adviser, Severens HTA Consultancy

Hans Severens | Scientific adviser | Severens HTA Consultancy » speaking at World EPA Congress

Navin Sewak, Global Market Access Director, ViiV Healthcare

Navin Sewak | Global Market Access Director | ViiV Healthcare » speaking at World EPA Congress

Helen Stoop, Head of Tender Excellence & PDT Payer Value, Takeda

Helen Stoop | Head of Tender Excellence & PDT Payer Value | Takeda » speaking at World EPA Congress

Teddy Sun, Evidence Generation Lead, Takeda

Teddy Sun | Evidence Generation Lead | Takeda » speaking at World EPA Congress

Jan Swiderski, Public Affairs & Advocacy Director, ipsen

Jan Swiderski | Public Affairs & Advocacy Director | ipsen » speaking at World EPA Congress

Monika Szkultecka-Debek, Vice President, Qualitas Vitae Institute Foundation

Monika Szkultecka-Debek | Vice President | Qualitas Vitae Institute Foundation » speaking at World EPA Congress

Giovanni Tafuri, Director International Market Access and Policy, Apellis Pharmaceuticals

Giovanni Tafuri | Director International Market Access and Policy | Apellis Pharmaceuticals » speaking at World EPA Congress

Peter Takacs, Global Business Operations, Miltenyi Biotec B.V. & Co. KG

Peter Takacs | Global Business Operations | Miltenyi Biotec B.V. & Co. KG » speaking at World EPA Congress

Sam Taylor, Emerging Markets Strategic Pricing Lead, Pfizer

Sam Taylor | Emerging Markets Strategic Pricing Lead | Pfizer » speaking at World EPA Congress

Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health

Ariella Toren | Director Of Medicine And Medical Technologies, Hmos Department | Israel - Ministry Of Health » speaking at World EPA Congress

Ilona Torontali, Global Head Pricing and Reimbursement, Roche

Ilona Torontali | Global Head Pricing and Reimbursement | Roche » speaking at World EPA Congress

Sheela Upadhyaya, Life Science Advisor in Rare Diseases & Special Advisor, Fipra

Sheela Upadhyaya | Life Science Advisor in Rare Diseases & Special Advisor | Fipra » speaking at World EPA Congress

Andreas Uttenweiler, Head Patient Value Access & Public Affairs, Takeda Pharma AG

Andreas Uttenweiler | Head Patient Value Access & Public Affairs | Takeda Pharma AG » speaking at World EPA Congress

Bart Van Den Daele, Head of External Affairs – Director Market Access - Belux, Gilead Sciences

Bart Van Den Daele | Head of External Affairs – Director Market Access - Belux | Gilead Sciences » speaking at World EPA Congress

Goedele Van Haasteren, Staff Member, Swiss Federal Office of Public Health

Goedele Van Haasteren | Staff Member | Swiss Federal Office of Public Health » speaking at World EPA Congress

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Medical Advisor, CZ

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani | Medical Advisor | CZ » speaking at World EPA Congress

Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia

Kärt Veliste | Chief Specialist at Department of Medicines and Medical Devices | Haigekassa Estonia » speaking at World EPA Congress

Kalman Wijaya, Head of Market Access, Versantis

Kalman Wijaya | Head of Market Access | Versantis » speaking at World EPA Congress

Lara J Wolfson, Executive Director and Head of Hta Statistics, Merck

Lara J Wolfson | Executive Director and Head of Hta Statistics | Merck » speaking at World EPA Congress

Natasa Zibelnik, Global Head of Value, Access and Pricing, Eusa Pharma

Natasa Zibelnik | Global Head of Value, Access and Pricing | Eusa Pharma » speaking at World EPA Congress

Zinajda Zolic-Karlsson, Senior Advisor HTA and Reimbursement, Norwegian Medicines Agency

Zinajda Zolic-Karlsson | Senior Advisor HTA and Reimbursement | Norwegian Medicines Agency » speaking at World EPA Congress

Zsombor Zrubka, Associate Professor - Department Of Health Economics, Obuda University

Zsombor Zrubka | Associate Professor - Department Of Health Economics | Obuda University » speaking at World EPA Congress

Get Involved 
 

To Sponsor Or Exhibit


David Boore 
david.boore@terrapinn.com
+44 20 8164 3052

To Speak


Francesca Wiggins
francesca.wiggins@terrapinn.com

Marketing Opportunities


Diana Cobzac
diana.cobzac@terrapinn.com